Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD?
Gabriel Tayguara Silveira Guerreiro, Larisse Longo, Mariana Alves Fonseca, Valessa Emanoele Gabriel de Souza, Mário Reis Álvares‐da‐Silva
Topics & Concepts
MedicineFatty liverInternal medicineGastroenterologySteatohepatitisSteatosisCirrhosisHepatocellular carcinomaLiver biopsyDiseaseBiopsyLiver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and LipoproteinsLiver Disease and Transplantation